Astrazeneca (AZN) Shares Outstanding (2009 - 2026)
Astrazeneca's Weighted Average Shares Outstanding was 1.55 billion in Q3 2026, unchanged from 1.55 billion a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Astrazeneca (AZN) Shares Outstanding (2009 - 2026) Analysis & Trends
From Q1 2009 onward, Astrazeneca has reported Weighted Average Shares Outstanding for 71 quarters.
- Weighted Average Shares Outstanding shows a five-year compound annual growth rate of 3.4% (FY2020 to FY2025).
- In earlier years, Weighted Average Shares Outstanding was 1.55 billion in FY2024 (+0.1%), 1.55 billion in FY2023 (+0.1%), 1.55 billion in FY2022 (+9.2%) and 1.42 billion in FY2021 (+8.1%).
- Compared with a year earlier, Weighted Average Shares Outstanding was higher in four of the last eight quarters, with an average year-over-year change of 0.0%.
- Over the past five years, the year-over-year growth in Weighted Average Shares Outstanding ranged from 0.0% (Q4 2025) to 9.2% (Q3 2023).
- Per Business Quant data, AZN's Weighted Average Shares Outstanding in the three quarters before Q3 2026 was 1.55 billion (Q2 2026), 1.55 billion (Q1 2026) and 1.55 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 891.90 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.41 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 1.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.47 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 1.94 Bn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 1.55 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 541.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.24 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.70 Bn |
| 10 | Vertex Pharmaceuticals | 138.90 Bn | 106.64 Bn | 2.91 Bn | 253.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.55 Bn |
| Jun 30, 2026 | 1.55 Bn |
| Mar 31, 2026 | 1.55 Bn |
| Dec 31, 2025 | 1.55 Bn |
| Sep 30, 2025 | 1.55 Bn |
| Jun 30, 2025 | 1.55 Bn |
| Mar 31, 2025 | 1.55 Bn |
| Dec 31, 2024 | 1.55 Bn |
| Sep 30, 2024 | 1.55 Bn |
| Jun 30, 2024 | 1.55 Bn |
| Mar 31, 2024 | 1.55 Bn |
| Dec 31, 2023 | 1.55 Bn |
| Sep 30, 2023 | 1.55 Bn |
| Jun 30, 2023 | 1.55 Bn |
| Mar 31, 2023 | 1.55 Bn |
| Dec 31, 2022 | 1.55 Bn |
| Sep 30, 2022 | 1.42 Bn |
| Jun 30, 2022 | 1.42 Bn |
| Mar 31, 2022 | 1.42 Bn |
| Dec 31, 2021 | 1.42 Bn |
API Access
Astrazeneca Shares Outstanding API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding&ticker=AZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding", "ticker": "AZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding&ticker=AZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();